The CliniMACS Prodigy® T Cell Transduction Process – A complete manufacturing solution
10.9 هزار بار بازدید -
4 سال پیش
-
For more information, visit
For more information, visit https://www.miltenyibiotec.com/applic... The CliniMACS Prodigy® T Cell Transduction (TCT) Process provides a unique all-in-one solution for the complex,manufacturing process of engineered T cells . The CliniMACS Prodigy Platform enables the generation of gene-modified T cells in a standardized and fully automated way. It is a breakthrough in cell manufacturing, a leap to the next generation of engineered cell manufacturing.
The TCT process with the CliniMACS Prodigy simplifies a complex procedure by allowing the complete automation of the process. The standardized procedure is robust and GMP-compliant. The closed system ensures product safety and reduces hand on time. Finally the process is both transferable and scalable, supporing centralized and decentralized manufacturing models.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has 2,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
The TCT process with the CliniMACS Prodigy simplifies a complex procedure by allowing the complete automation of the process. The standardized procedure is robust and GMP-compliant. The closed system ensures product safety and reduces hand on time. Finally the process is both transferable and scalable, supporing centralized and decentralized manufacturing models.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has 2,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
4 سال پیش
در تاریخ 1399/04/18 منتشر شده
است.
10,917
بـار بازدید شده